Astrazeneca

Astrazeneca

Astrazeneca Socially Speaking

Astrazeneca News, Fundamentals and Discussion on:

Interactive Investor | Financial Times | ADVFN | Motley Fool | Proactive Investors
Ayondo
Ayondo

Astrazeneca on Social Media


Astrazeneca RNS, News & Media


Headline
26 Jul 2017
RNS press release - Faslodex receives EU approval for 1L breast cancer from Proactive Investors
21 Jul 2017
RNS press release - Holding(s) in Company from Proactive Investors
13 Jul 2017
News - AstraZeneca plummets on reports that CEO Pascal Soriot is set to join Israeli competitor Teva from Proactive Investors
3 Jul 2017
RNS press release - Total Voting Rights from Proactive Investors
3 Jul 2017
RNS press release - AZ COMPLETES SELOKEN AGREEMENT WITH RECORDATI from Proactive Investors
3 Jul 2017
RNS press release - AZ COMPLETES ZOMIG DIVESTMENT WITH GR�œNENTHAL from Proactive Investors
23 Jun 2017
RNS press release - Faslodex CHMP positive opinion in 1L breast cancer from Proactive Investors
23 Jun 2017
News - GlaxoSmithKline and AstraZeneca among drug stocks buoyed by Trump's healthcare plans from Proactive Investors
7 Jun 2017
News - AstraZeneca raises initial US$200mln from sale of global rights to its Zomig treatment for migraines and cluster headaches from Proactive Investors
7 Jun 2017
RNS press release - AZ agreement with Grünenthal for rights to Zomig from Proactive Investors
6 Jun 2017
RNS press release - ASTRAZENECA PRICES A $2BN BOND ISSUE from Proactive Investors
5 Jun 2017
News - ASCO 2017: AstraZeneca's breast cancer treatment leads the way from Proactive Investors
5 Jun 2017
News - AstraZeneca's Lynparza breast cancer drug impresses in phase III trial from Proactive Investors
5 Jun 2017
RNS press release - LYNPARZA: SIGNIFICANT PFS IN BRCAm BREAST CANCER from Proactive Investors
1 Jun 2017
RNS press release - Block listing Interim Review from Proactive Investors
1 Jun 2017
RNS press release - Total Voting Rights from Proactive Investors
31 May 2017
RNS press release - Directorate Change from Proactive Investors
24 May 2017
RNS press release - Director/PDMR Shareholding from Proactive Investors
23 May 2017
RNS press release - Bydureon EXSCEL trial meets T2D safety objective from Proactive Investors
22 May 2017
RNS press release - AZ AGREEMENT WITH RECORDATI FOR SELOKEN IN EUROPE from Proactive Investors
17 May 2017
News - AstraZeneca PLC 'one for the brave', but still a 'buy', according to leading City broker from Proactive Investors
16 May 2017
RNS press release - Director/PDMR Shareholding from Proactive Investors
15 May 2017
News - Lung cancer success means AstraZeneca now has a "significant lead" over competitors from Proactive Investors
12 May 2017
News - AstraZeneca, Merck and Bristol-Myers vying for dominance in lung cancer market from Proactive Investors
12 May 2017
News - AstraZeneca reports "highly encouraging" initial results from its PACIFIC lung cancer trial from Proactive Investors
12 May 2017
RNS press release - IMFINZI SIGNIFICANT PFS - UNRESECTABLE LUNG CANCER from Proactive Investors
10 May 2017
RNS press release - AZ updates on tralokinumab trial in severe asthma from Proactive Investors
5 May 2017
Media files - Is oil heading to US$41? - Tip TV from Proactive Investors
2 May 2017
RNS press release - Total Voting Rights from Proactive Investors
2 May 2017
News - US Food & Drug administration gives accelerated approval to drug that uses body's immune system to fight cancer from Proactive Investors
2 May 2017
RNS press release - DURVALUMAB RECEIVES US FDA ACCELERATED APPROVAL from Proactive Investors
27 Apr 2017
RNS press release - Result of AGM from Proactive Investors
27 Apr 2017
News - AstraZeneca's new drugs can't come quick enough from Proactive Investors
27 Apr 2017
RNS press release - AstraZeneca: Q1 2017 Results from Proactive Investors
25 Apr 2017
RNS press release - TAGRISSO RECEIVES FULL APPROVAL IN THE EU from Proactive Investors
10 Apr 2017
News - Drugs giant AstraZeneca's recommendation cut by Jefferies from Proactive Investors
31 Mar 2017
News - Drug developer AstraZeneca shares mark time after FDA approval for lung cancer drug from Proactive Investors
20 Mar 2017
News - AstraZeneca's diabetes drug data shows significant cut in death rates from Proactive Investors
17 Mar 2017
News - FDA deals another blow to AstraZeneca's ZS-9 blood drug from Proactive Investors
8 Mar 2017
News - Barclays Capital analysts "resoundingly positive" on pharma stocks; AstraZeneca top pick from Proactive Investors
28 Feb 2017
News - US FDA approves AstraZeneca combination drug for treatment of type-2 diabetes from Proactive Investors
21 Feb 2017
Media files - Look for dips in AstraZeneca share price - Zak Mir from Proactive Investors
20 Feb 2017
News - AstraZeneca sells commercial rights to Zoladex cancer treatment from Proactive Investors
17 Feb 2017
News - AstraZeneca reveals positive breast cancer treatment trial results; Woodford adds to holding from Proactive Investors
2 Feb 2017
News - AstraZeneca: Never mind the sales, look at the dividend yield from Proactive Investors
27 Jan 2017
Media files - Analysis charts an opportunity to buy AstraZeneca shares - Zak Mir from Proactive Investors
17 Jan 2017
News - AstraZeneca rejigs MYSTIC lung cancer study from Proactive Investors
23 Dec 2016
RNS press release - AZ COMPLETES SALE OF ANTIBIOTICS BUSINESS from Proactive Investors
16 Dec 2016
RNS press release - Director/PDMR Shareholding from Proactive Investors

Astrazeneca 3 Month Chart